Arrowhead Stock Buy Hold or Sell Recommendation

ARWR
 Stock
  

USD 33.96  2.76  8.85%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Arrowhead Pharma is 'Hold'. Macroaxis provides Arrowhead Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ARWR positions. The advice algorithm takes into account all of Arrowhead Pharma's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Arrowhead Pharma's buy-and-hold perspective. Please continue to Arrowhead Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Arrowhead and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Arrowhead Pharma.

Execute Arrowhead Pharma Buy or Sell Advice

The Arrowhead recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Arrowhead Pharma. Macroaxis does not own or have any residual interests in Arrowhead Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Arrowhead Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Arrowhead PharmaBuy Arrowhead Pharma
Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Reporting Quality (M-Score)

Details
For the selected time horizon Arrowhead Pharma has a Risk Adjusted Performance of (0.020366), Jensen Alpha of (0.08), Total Risk Alpha of 0.193 and Treynor Ratio of (0.42)
Our advice module can be used to complement Arrowhead Pharma investment recommendation provided by average analyst sentiment. It analyzes the company's potential to grow using fundamental, technical, data market data available at the time. To make sure Arrowhead Pharma is not overpriced, please confirm all Arrowhead Pharma fundamentals, including its total debt, and the relationship between the revenue and earnings per share . Given that Arrowhead Pharma has a number of shares shorted of 4.18 M, we suggest you to validate Arrowhead Pharma market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Arrowhead Pharma Trading Alerts and Improvement Suggestions

Arrowhead Pharma has very high historical volatility over the last 90 days
Arrowhead Pharma is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 249.94 M. Net Loss for the year was (153.93 M) with profit before overhead, payroll, taxes, and interest of 138.29 M.
Arrowhead Pharma currently holds about 416.5 M in cash with (91.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.93.
Roughly 70.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Swelling losses havent held back gains for Arrowhead Pharmaceuticals shareholders since theyre up 566 percent over 5 years - Simply Wall St

Arrowhead Pharma current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arrowhead analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arrowhead analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price74.46
Target Median Price79.00
Target High Price110.00
Recommendation Mean2.00
Number Of Analyst Opinions13
Target Low Price39.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Arrowhead Pharma Returns Distribution Density

The distribution of Arrowhead Pharma's historical returns is an attempt to chart the uncertainty of Arrowhead Pharma's future price movements. The chart of the probability distribution of Arrowhead Pharma stock daily returns describes the distribution of returns around its average expected value. We use Arrowhead Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Arrowhead Pharma returns is essential to provide solid investment advice for Arrowhead Pharma.
Mean Return-0.09Value At Risk-4.53
Potential Upside5.57Standard Deviation3.59
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Arrowhead Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Arrowhead Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Arrowhead Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arrowhead Pharma backward and forwards among themselves. Arrowhead Pharma's institutional investor refers to the entity that pools money to purchase Arrowhead Pharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares12.3 M432.5 M
Vanguard Group IncCommon Shares10.1 M354.5 M
State Street CorpCommon Shares5.6 M196.6 M
Jpmorgan Chase CoCommon SharesM105.3 M
Alliancebernstein LpCommon Shares2.8 M98.5 M
Fmr LlcCommon Shares2.7 M96.6 M
Invesco LtdCommon Shares2.2 M77.5 M
Note, although Arrowhead Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arrowhead Pharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arrowhead Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arrowhead Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arrowhead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.08
β
Beta against DOW0.23
σ
Overall volatility
3.71
Ir
Information ratio -0.0018

Arrowhead Pharma Volatility Alert

Arrowhead Pharma exhibits very low volatility with skewness of 0.18 and kurtosis of -0.35. However, we advise investors to further study Arrowhead Pharma technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arrowhead Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arrowhead Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Arrowhead Pharma Fundamentals Vs Peers

Comparing Arrowhead Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arrowhead Pharma's direct or indirect competition across all of the common fundamentals between Arrowhead Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arrowhead Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Arrowhead Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Arrowhead Pharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Arrowhead Pharma to competition
FundamentalsArrowhead PharmaPeer Average
Return On Equity(33.79) %(0.31) %
Return On Asset(13.41) %(0.14) %
Profit Margin(61.58) %(1.27) %
Operating Margin(59.73) %(5.51) %
Current Valuation2.96 B16.62 B
Shares Outstanding105.85 M571.82 M
Shares Owned by Insiders2.65 %10.09 %
Shares Owned by Institutions69.61 %39.21 %
Number of Shares Shorted4.18 M4.71 M
Price to Earning482.39 X28.72 X
Price to Book7.21 X9.51 X
Price to Sales13.34 X11.42 X
Revenue249.94 M9.43 B
Gross Profit138.29 M27.38 B
EBITDA(149.3 M)3.9 B
Net Income(153.93 M)570.98 M
Cash and Equivalents416.5 M2.7 B
Cash per Share3.93 X5.01 X
Total Debt81.11 M5.32 B
Debt to Equity0.17 %48.70 %
Current Ratio3.37 X2.16 X
Book Value Per Share4.29 X1.93 K
Cash Flow from Operations(91.58 M)971.22 M
Short Ratio5.71 X4.00 X
Earnings Per Share(1.08) X3.12 X
Price to Earnings To Growth(3.66) X4.89 X
Number of Employees32918.84 K
Beta1.41-0.15
Market Capitalization3.33 B19.03 B
Total Asset128.18 M29.47 B
Retained Earnings(407.15 M)9.33 B
Working Capital64.86 M1.48 B
Current Asset90.5 M9.34 B
   Disposition of 551197 shares by Christopher Anzalone of Arrowhead Pharma subject to Rule 16b-3 [view details]

Arrowhead Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Arrowhead . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Arrowhead Pharma Buy or Sell Advice

When is the right time to buy or sell Arrowhead Pharma? Buying financial instruments such as Arrowhead Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Arrowhead Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beers Thematic Idea Now

Beers
Beers Theme
Companies involved in production and distribution of domestic and international beer. The Beers theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Arrowhead Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.